References
For references and further reading materials, see below:
• Arecco L, Blondeaux E, Bruzzone M et al. Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis. ESMO Open. 2023 Dec;8(6):102031.
• Bedfordshire Hospitals Foundation NHS Trust. Wilson’s criteria for screening.
• BMS. The benefits and risks of HRT before and after a breast cancer diagnosis. March 2024.
• BMS. Non-hormonal-based treatment for menopausal symptoms. Sept 2024.
• CRUK. A study to identify early signs of cancer of the pancreas (EUROPAC).
• CRUK. Clinical decision support tools.
• CRUK. FIT symptomatic.
• CRUK. GP and practice insight guides.
• CRUK. I’m trans or non-binary, does this affect my cancer screening?
• CRUK. Local cancer statistics.
• CRUK. Safety netting.
• CRUK. What is cervical screening?
• DHSC. Biggest prostate cancer screening trial in decades to start in UK. Nov 2023.
• FSRH. Supporting Contraceptive Choices for Individuals Who Have or Have Had Breast Cancer. Nov 2023.
• Macmillan. Late effects of cancer treatment.
• Marzorati C, Riva S, Pravettoni G. Who Is a Cancer Survivor? A Systematic Review of Published Definitions. J Cancer Educ. 2017 Jun;32(2):228-237.
• Mitchell AJ, Ferguson DW, Gill J et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013 Jul;14(8):721-32
• National Centre for Smoking Cessation and Training. Cytisine. March 2024.
• National Centre for Smoking Cessation and Training. Very brief advice on smoking. 2021.
• NHS England. Breast screening: high risk women. Sept 2024.
• NHS England. Breast screening: programme overview. July 2024.
• NHS England. Cervical screening: programme overview. July 2024.
• NHS England. Early cancer diagnosis in England reaches highest ever level. Jan 2025.
• NHS England. Presentation: Patient with a family history of bowel cancer. 2025.
• NHS England. NHS population screening: information for trans and non-binary people. April 2025.
• NICE. NG12. Suspected cancer: recognition and referral. April 2025.
• NICE. CG164. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Nov 2023.
• NICE. NG23. Menopause: identification and management. Nov 2024.
• NICE CKS. Smoking cessation. Aug 2024.
• Niedzwiedz CL, Knifton L, Robb KA et al. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019 Oct 11;19(1):943.
• Nolan K, Boland MR, Hill ADK. Pregnancy After Breast Cancer - Prognostic Safety and Pregnancy Outcomes According to Oestrogen Receptor Status: A Systematic Review. J Breast Cancer. 2022 Dec;25(6):443-453.
• Office for Health Improvement and Disparities. Nicotine vaping in England: an evidence update including health risks and perceptions, 2022. Sept 2022.
• Office for National Statistics. Adult smoking habits in the UK: 2023. Oct 2024
• Prostate cancer UK. Transform trial.
• Public Health England. HPV primary cervical screening pilot report published in BMJ. Feb 2019.
• Public Health England. Reducing cervical screening inequalities for trans people. April 2019.
• RCGP. The Daffodil Standards.
• RCP. E-cigarettes and harm reduction: An evidence review. April 2024.
• Smith CF, Drew S, Ziebland S et al. Understanding the role of GPs’ gut feelings in diagnosing cancer in primary care: a systematic review and meta-analysis of existing evidence. British Journal of General Practice. 2020 Sep 1;70(698):e612-21.
• UK National Screening Committee. Prostate cancer. 2020.
• UK National Screening Committee. Timely detection of thousands of cancers underlines benefits of a national lung cancer screening programme. Nov 2024.
• University of the West of Scotland. Assessment and care planning for cancer survivors. Jan 2014.
• Watson EK, Rose PW, Loftus R et al. Cancer survivorship: the impact on primary care. Br J Gen Pract. 2011 Nov;61(592):e763-5.
• Watson J, Mounce L, Bailey SE et al. Blood markers for cancer. BMJ. 2019 Oct 14;367.